Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...

The new facility will enable production of 25 million more patient doses per year of contrast media by the end of 2027.

GE HealthCare has inked a nearly $248 million deal with Nuffield Health, a large, independent, not-for-profit health care provider in the United Kingdom. The multiyear agreement calls for Chicago ...

GE HealthCare has announced a €132m investment to expand its facility in Cork where they manufacture contrast media - diagnostic imaging agents used in CT scans and X-Rays. A new 3000m2 facility ...

American Hospital Dubai has signed a Memorandum of Understanding (MoU) with GE HealthCare, and its partner Abu Dhabi International Medical Services (ADI), which will see GE HealthCare’s most ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 61 figures, this 133-page report Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, ...

SAN FRANCISCO—GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at improving the diagnosis of neurodegenerative diseases and ...